Anticorps CCR5 PA14

European patent · EP1144006 · Deleted

Register entry

Publication number: EP1144006
Application number: EP99966466
Kind: European patent with effect for Switzerland and Liechtenstein
Status: Deleted
Specification: Granted
Filed: Dec 16, 1999
Published: Oct 17, 2001
Granted: Oct 17, 2007
Deleted: Dec 31, 2010
Reason: Annual fee unpaid
IPC classes: A61K 39/21 (2006.01)
A61K 39/40 (2006.01)
A61K 39/42 (2006.01)
C12N 5/06 (2006.01)
C12N 7/00 (2006.01)
C12N 7/04 (2006.01)
C12N 7/06 (2006.01)
C12Q 1/70 (2006.01)
A61K 39/395 (2006.01)
C07K 16/28 (2006.01)
Priority: US 212793 16.12.1998
US 112532 P 16.12.1998
PCT application: PCT/US1999/030345 16.12.1999
PCT publication: WO2000/035409 22.06.2000
Filing language: English
Source: Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

Jul 20, 2011
Deleted, fee unpaid
Published in Swissreg on 20.07.2011
Nov 15, 2007
Granted
Published in +pat+ No 21 in 2007
Nov 15, 2007
Agent entered
Representative
E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in +pat+ No 21 in 2007

Parties

Holder

Progenics Pharmaceuticals, Inc.

PROGENICS PHARMACEUTICALS, INC.

777 Old Saw Mill River Road, Tarrytown, NY 10591, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

OLSON, William, C.

Ossining, NY 10562, US

MADDON, Paul, J.

Scarsdale, NY 10583, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.